GlassScriptPhysician profile
Priti T Modi
NPI 1568440246
$5,487.90
in general payments reported to CMS, 2019-2025
46 companies · $1,019 in 2025
The $1,019 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,015 · 2020: $15.84 · 2021: $321 · 2022: $599 · 2023: $978 · 2024: $1,541 · 2025: $1,019.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,487 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,487.32 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $888.34 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $552.29 | 2019-2025 | Jardiance, Ofev, Jascayd |
| Corcept Therapeutics | $503.62 | 2019-2024 | Korlym |
| Lilly USA, LLC | $356.76 | 2023-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $343.44 | 2022-2025 | Repatha, Otezla, Evenity |
| Novo Nordisk INC | $268.53 | 2019-2025 | Ozempic |
| Novartis Pharmaceuticals Corporation | $259.34 | 2019-2025 | |
| Astellas Pharma US INC | $195.53 | 2019-2024 | Veozah |
| Sanofi-Aventis U.S. LLC | $186.11 | 2019 | |
| Pfizer INC. | $169.10 | 2019-2025 | |
| Xeris Pharmaceuticals, INC. | $152.58 | 2021-2025 | Recorlev, Gvoke Hypopen |
| Bayer Healthcare Pharmaceuticals INC. | $148.95 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $140.90 | 2019-2025 | Rexulti, Nuedexta |
| Glaxosmithkline, LLC. | $118.16 | 2019-2025 | Trelegy Ellipta |
| Abbvie INC. | $117.16 | 2021-2024 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priti Modi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.